International Clinical Trial: Real-World Effectiveness of Adding Haibomeib on Top of Statin Therapy for Very High-Risk ASCVD

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119419) titled 'Real-World Effectiveness of Adding Haibomeib on Top of Statin Therapy for Very High-Risk ASCVD' on Feb. 26.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

Condition: high-risk atherosclerotic cardiovascular disease (ASCVD)

Intervention: statin:N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-26

Target Sample Size: statin:130;Hybutimibe Tablets and statin:130;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=311608

Publi...